Shanghai No 1 Pharmacy Co (SHSE:600833) Piotroski F-Score: 5 (As of Jul. 21, 2026) — 17% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600833 Shanghai No 1 Pharmacy Co Ltd SHSE:600833
56 GF Score
Price ¥9.48
GF Value ¥12.83
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Shanghai No 1 Pharmacy Co Piotroski F-Score?

Shanghai No 1 Pharmacy Co SHSE:600833 -1.96% 56 Piotroski F-Score is 5 as of Jul. 21, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates SHSE:600833 with a GF Score™ of 56/100 and a GF Value™ of ¥12.83 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 646 Healthcare Providers & Services companies, Shanghai No 1 Pharmacy Co ranks better than 54.49% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai No 1 Pharmacy Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Shanghai No 1 Pharmacy Co's Piotroski F-Score or its related term are showing as below:

SHSE:600833' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 6   Max: 8
Current: 5

During the past 13 years, the highest Piotroski F-Score of Shanghai No 1 Pharmacy Co was 8. The lowest was 3. And the median was 6.

Shanghai No 1 Pharmacy Co  (SHSE:600833) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Shanghai No 1 Pharmacy Co Piotroski F-Score Related Terms


Shanghai No 1 Pharmacy Co Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Shanghai No 1 Pharmacy Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai No 1 Pharmacy Co Piotroski F-Score Chart

Shanghai No 1 Pharmacy Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.00 8.00 4.00 5.00 6.00

Shanghai No 1 Pharmacy Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.00 6.00 5.00 6.00 5.00

Shanghai No 1 Pharmacy Co Piotroski F-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Shanghai No 1 Pharmacy Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai No 1 Pharmacy Co Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Shanghai No 1 Pharmacy Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Shanghai No 1 Pharmacy Co's Piotroski F-Score falls into.


SHSE:600833
56GF Score
Shanghai No 1 Pharmacy Co Ltd SHSE:600833
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was 9.285 + 39.246 + 4.477 + 23.263 = ¥76 Mil.
Cash Flow from Operations was 42.839 + -30.994 + 64.339 + 8.349 = ¥85 Mil.
Revenue was 492.633 + 542.481 + 591.157 + 484.557 = ¥2,111 Mil.
Gross Profit was 79.416 + 85.809 + 90.868 + 71.195 = ¥327 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(1987.73 + 2008.575 + 2030.694 + 2021.324 + 1991.02) / 5 = ¥2007.8686 Mil.
Total Assets at the begining of this year (Mar25) was ¥1,988 Mil.
Long-Term Debt & Capital Lease Obligation was ¥109 Mil.
Total Current Assets was ¥1,042 Mil.
Total Current Liabilities was ¥615 Mil.
Net Income was 93.735 + 17.536 + 15.736 + 4.739 = ¥132 Mil.

Revenue was 431.098 + 475.709 + 546.279 + 503.964 = ¥1,957 Mil.
Gross Profit was 68.696 + 78.98 + 89.694 + 85.41 = ¥323 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(1855.15 + 1927.702 + 1928.998 + 1980.057 + 1987.73) / 5 = ¥1935.9274 Mil.
Total Assets at the begining of last year (Mar24) was ¥1,855 Mil.
Long-Term Debt & Capital Lease Obligation was ¥104 Mil.
Total Current Assets was ¥1,201 Mil.
Total Current Liabilities was ¥663 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai No 1 Pharmacy Co's current Net Income (TTM) was 76. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Shanghai No 1 Pharmacy Co's current Cash Flow from Operations (TTM) was 85. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=76.271/1987.73
=0.03837091

ROA (Last Year)=Net Income/Total Assets (Mar24)
=131.746/1855.15
=0.07101636

Shanghai No 1 Pharmacy Co's return on assets of this year was 0.03837091. Shanghai No 1 Pharmacy Co's return on assets of last year was 0.07101636. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Shanghai No 1 Pharmacy Co's current Net Income (TTM) was 76. Shanghai No 1 Pharmacy Co's current Cash Flow from Operations (TTM) was 85. ==> 85 > 76 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=108.952/2007.8686
=0.05426251

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=104.3/1935.9274
=0.05387599

Shanghai No 1 Pharmacy Co's gearing of this year was 0.05426251. Shanghai No 1 Pharmacy Co's gearing of last year was 0.05387599. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=1041.74/615.224
=1.69326944

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=1201.197/663.23
=1.81113188

Shanghai No 1 Pharmacy Co's current ratio of this year was 1.69326944. Shanghai No 1 Pharmacy Co's current ratio of last year was 1.81113188. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Shanghai No 1 Pharmacy Co's number of shares in issue this year was 223.035. Shanghai No 1 Pharmacy Co's number of shares in issue last year was 223.542. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=327.288/2110.828
=0.15505195

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=322.78/1957.05
=0.16493191

Shanghai No 1 Pharmacy Co's gross margin of this year was 0.15505195. Shanghai No 1 Pharmacy Co's gross margin of last year was 0.16493191. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=2110.828/1987.73
=1.06192893

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=1957.05/1855.15
=1.05492817

Shanghai No 1 Pharmacy Co's asset turnover of this year was 1.06192893. Shanghai No 1 Pharmacy Co's asset turnover of last year was 1.05492817. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+0+0+1+0+1
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Shanghai No 1 Pharmacy Co has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Shanghai No 1 Pharmacy Co (SHSE:600833) has a Piotroski F-Score of 5 as of Jul. 21, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai No 1 Pharmacy Co and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Shanghai No 1 Pharmacy Co's Piotroski F-Score has ranged from 3.00 to 8.00. According to the industry distribution chart, Shanghai No 1 Pharmacy Co ranks #294 out of 646 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is Shanghai No 1 Pharmacy Co's Piotroski F-Score too high?
Shanghai No 1 Pharmacy Co's current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 8.00. The Healthcare Providers & Services industry median Piotroski F-Score is 5.00. Shanghai No 1 Pharmacy Co's value of 5 is 0% at this industry median. Based on the distribution chart, Shanghai No 1 Pharmacy Co ranks #294 out of 646 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Shanghai No 1 Pharmacy Co has a GF Score™ of 56/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai No 1 Pharmacy Co's Piotroski F-Score compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Shanghai No 1 Pharmacy Co ranks #294 out of 646 companies for Piotroski F-Score. This puts Shanghai No 1 Pharmacy Co in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Shanghai No 1 Pharmacy Co's value of 5 is 0% at this benchmark. Historically, Shanghai No 1 Pharmacy Co's own Piotroski F-Score has ranged from 3.00 to 8.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Shanghai No 1 Pharmacy Co has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Healthcare Providers & Services company?
The median Piotroski F-Score among Healthcare Providers & Services companies is 5.00, based on 646 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai No 1 Pharmacy Co's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai No 1 Pharmacy Co and its competitors. For the Healthcare Providers & Services industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai No 1 Pharmacy Co's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai No 1 Pharmacy Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co (SHSE:600833) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥12.83, compared to a current price of ¥9.48 — trading 26.1% below its estimated fair value. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Healthcare Providers & Services industry median of 5.00. Shanghai No 1 Pharmacy Co's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shanghai No 1 Pharmacy Co (SHSE:600833), the current Piotroski F-Score is 5 as of Jul. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shanghai No 1 Pharmacy Co (SHSE:600833) Overvalued in 2026?

Based on GuruFocus' analysis, Shanghai No 1 Pharmacy Co stock appears to be undervalued. The current stock price of ¥9.48 is trading 26.1% below its estimated GF Value™ of ¥12.83. GuruFocus considers Shanghai No 1 Pharmacy Co to be Modestly Undervalued.

Key valuation signals for SHSE:600833:

  • Piotroski F-Score: 5 (17% below median its 10-year median of 6.00)
  • GF Value™: ¥12.83 vs. price of ¥9.48 (26.1% below fair value)
  • GF Score™: 56/100 with 6 warning signs
  • Industry Position: 0% at the Healthcare Providers & Services median (#294 of 646)

No single metric tells the full story. See the SHSE:600833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shanghai No 1 Pharmacy Co Business Description

Address No. 616 Nanjing East Road, Huangpu District, Shanghai, CHN, 200032
Shanghai No 1 Pharmacy Co Ltd is engaged in pharmaceutical retail and wholesale in China. The company's product profile include Lei Shi Pearl Powder, Tongrentang Ejiao Powder, Wanshuntang Yangyin mouth fragrance mixture, and others. It also provides Nourishing health Nutrition, Medical instruments, Rehabilitation care, Contact lens, and others.
56GF Score

Get the complete analysis for SHSE:600833

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥9.48
Price
¥12.83
GF Value